Vivos Inc (QB) (RDGL) Fundamentals

Vivos Inc, developed an yttrium-90 brachytherapy device to combat cancer in humans and animals. Testing at Washington State University, the University of Missouri and our pilot veterinary clinic has verified the safety to the patient, the therapist and the family members. IsoPet is commercially available for animal therapy and can deliver very high doses to solid tumors with a single same day therapy. Pre-clinical testing is in progress to generate key data for an Investigational Devise Exemption to the FDA to begin human clinical trials.
Share Info
Market Cap$ 25,020,306
Shares Authorized950,000,000
Shares Outstanding342,743,915
Shares Outstanding Date05/13/2022
Shareholder Count230
Shareholder Count Date03/07/2022
Float Date01/04/2022
Short Interest14,295
Short Interest Date04/29/2022
Reporting Info
Reporting StatusSEC Reporting
Audit StatusYes
AuditorFruci & Associates II, PLLC
Auditor Address802 N. Washington St.
Spokane, Washington 99201
Auditor Website
IR Firm-
IR Firm Address-
IR Firm Website-
Legal CounselDisclosure Law Group
Legal Counsel Address655 West Broadway, Suite 870
San Diego, California 92101
Legal Counsel Website
Fiscal Year End12/31
ADR Ratio-
Transfer AgentPacific Stock Transfer Co.
Transfer Agent Address6725 Via Austi Parkway
Suite 300
Las Vegas, NV 89119
Depository Website
SHO Flag-
3210 Flag-
Company Info
Ticker SymbolUSOTC:RDGL
OTC Market TierOTCQB
Security TypeCommon Stock
CIK Number0001449349
Address719 Jadwin Avenue
Richland, Washington 99352
Phone(509) 736-4000
Fax #509-736-4007
SIC Code / Description3841 / Surgical and medical instruments
Key ExecutivesInterim CFO - Michael Pollack
Chairman - Dr. Carlton Cadwell
CEO - Dr. Michael Korenko
Number of Employees1
Incorporation StateDelaware
Incorporation CountryUSA
Incorporation Year-

Your Recent History
Vivos (QB)
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.